Synthesis and characterization of a novel biocompatible pseudo-hexagonal NaCa-layered double metal hydroxides for smart pH-responsive drug release of dacarbazine and enhanced anticancer activity in malignant melanoma

Synergistic chemoimmunotherapy in a green framework: pH-responsive natural plant polysaccharide-based nanoparticles

Traditional therapies are inadequate in addressing the escalating threat of cancer, highlighting the urgent need for more effective treatment modalities. Natural products play a crucial role in the development of novel anticancer pharmaceuticals and safe anti-tumor nanomedicines. Honokiol (HK), a naturally occurring compound, has been shown to induce apoptosis in cancer cells and inhibit tumor proliferation, positioning it as a promising candidate for chemotherapeutic applications. While, plant-derived polysaccharides are known to activate anti-tumor immune responses and exhibit favorable properties such as biocompatibility, safety, and modifiability, making them suitable carriers for drug delivery. In this study, golden berries (the fruits of Physalis peruviana) polysaccharides (PPP), which exhibit immune-stimulating properties, were integrated with the crosslinking agent benzene-1,4-diboronic acid (BDBA) to develop pH-responsive nanoparticles (HK@PPP-BDBA) for synergistic chemo-immunotherapy. We conducted a comprehensive chemical characterization of the nanoparticles and investigated the molecular mechanisms underlying the assembly of HK and polysaccharides through computational simulations. The HK@PPP-BDBA demonstrated significant inhibitory effects on the proliferation of MCF-7 and HeLa cells, reduced tumor growth, and impeded cancer cell migration in vivo. HK promoted the production of reactive oxygen species (ROS) and apoptosis in tumor cells, while PPP facilitated the maturation of dendritic cells, enhanced the expression of costimulatory molecules and histocompatibility complex, and initiated anti-tumor immunity. The advancement of HK@PPP-BDBA expands the potential applications of natural polysaccharides and nanoparticles in cancer treatment, offering a promising platform for the integration of chemotherapy and immunotherapy.

Solubilization techniques used for poorly water-soluble drugs

About 40% of approved drugs and nearly 90% of drug candidates are poorly water-soluble drugs. Low solubility reduces the drugability. Effectively improving the solubility and bioavailability of poorly water-soluble drugs is a critical issue that needs to be urgently addressed in drug development and application. This review briefly introduces the conventional solubilization techniques such as solubilizers, hydrotropes, cosolvents, prodrugs, salt modification, micronization, cyclodextrin inclusion, solid dispersions, and details the crystallization strategies, ionic liquids, and polymer-based, lipid-based, and inorganic-based carriers in improving solubility and bioavailability. Some of the most commonly used approved carrier materials for solubilization techniques are presented. Several approved poorly water-soluble drugs using solubilization techniques are summarized. Furthermore, this review summarizes the solubilization mechanism of each solubilization technique, reviews the latest research advances and challenges, and evaluates the potential for clinical translation. This review could guide the selection of a solubilization approach, dosage form, and administration route for poorly water-soluble drugs. Moreover, we discuss several promising solubilization techniques attracting increasing attention worldwide.

Sustained antibacterial release of zwitterionic globular hyperbranched polymer dots intercalated into layered double hydroxides

This study introduces zwitterionic hyperbranched polymer (HBP) dots intercalated into layered double hydroxides (LDHs) for sustained antibacterial release. The proposed zwitterionic HBPs possess a three-dimensional spherical structure; unconventional blue fluorescent luminescence; water solubility; abundant COOH, amine, and amide functional groups; anionic exchangeability for intercalating into LDH interlayers; and sustained-release antibacterial activity. The intercalation for the layered nanomaterials was determined by adding different weight ratios of HBPs to Mg-Al LDHs to investigate the changes in the interlayer distance. X-ray diffraction revealed that the LDH layer spacing increased from 8.6 to 25.5 Å, effectively expanding the interlayer spacing with increasing HBP intercalation. Additionally, Fourier-transform infrared spectroscopy revealed the functional groups of the intercalated nanohybrids. Because the peripheral functional groups of HBPs are amino (-NH2) groups, preliminary evaluations revealed that pristine HBPs exhibited antibacterial properties. We further examined the antibacterial properties of the HBP/LDH nanohybrids. The results showed that HBPs combined with LDHs' controllable release properties can effectively achieve long-term sustained antibacterial release.

Layered Double Hydroxides: Recent Progress and Promising Perspectives Toward Biomedical Applications

Layered double hydroxides (LDHs) have been widely studied for biomedical applications due to their excellent properties, such as good biocompatibility, degradability, interlayer ion exchangeability, high loading capacity, pH-responsive release, and large specific surface area. Furthermore, the flexibility in the structural composition and ease of surface modification of LDHs makes it possible to develop specifically functionalized LDHs to meet the needs of different applications. In this review, the recent advances of LDHs for biomedical applications, which include LDH-based drug delivery systems, LDHs for cancer diagnosis and therapy, tissue engineering, coatings, functional membranes, and biosensors, are comprehensively discussed. From these various biomedical research fields, it can be seen that there is great potential and possibility for the use of LDHs in biomedical applications. However, at the same time, it must be recognized that the actual clinical translation of LDHs is still very limited. Therefore, the current limitations of related research on LDHs are discussed by combining limited examples of actual clinical translation with requirements for clinical translation of biomaterials. Finally, an outlook on future research related to LDHs is provided.

State-of-the-art advancement of surface functionalized layered double hydroxides for cell-specific targeting of therapeutics

Over the years, layered double hydroxides (LDHs) hold a specific position in biomedicine due to their tunable chemical composition and appropriate structural properties. However, LDHs lack adequate sensitivity for active targeting because of less active surface area and low mechanical strength in physiological conditions. The exploitation of eco-friendly materials, such as chitosan (CS), for surface engineering of LDHs, whose payloads are transferred only under certain conditions, can help develop stimuli-responsive materials owing to high biosafety and unique mechanical strength. We aim to render a well-oriented scenario toward the latest achievements of a bottom-up technology relying on the surface functionalization of LDHs to fabricate functional formulations with promoted bio-functionality and high encapsulation efficiency for various bioactives. Many efforts have been devoted to critical aspects of LDHs, including systemic biosafety and the suitability for developing multicomponent systems via integration with therapeutic modalities, which are thoroughly discussed herein. In addition, a comprehensive discussion was provided for the recent progress in the emergence of CS-coated LDHs. Finally, the challenges and future perspectives in the fabrication of efficient CS-LDHs in biomedicine are considered, with a special focus on cancer treatment.

Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma

Melanoma is one of the most severe cancerous diseases. The cells employ multiple signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell proliferation, survival, and metastasis. Treatment of melanoma, including surgery, chemotherapy, immunotherapy, radiation, and targeted therapy, is based on 4 major or 11 substages of the disease. Fourteen drugs, including dacarbazine, interferon α-2b, interleukin-12, ipilimumab, peginterferon α-2b, vemurafenib, trametinib, talimogene laherparepvec, cobimetinib, pembrolizumab, dabrafenib, binimetinib, encorafenib, and nivolumab, have been approved by the FDA for the treatment of melanoma. All of them are in conventional dosage forms of injection solutions, suspensions, oral tablets, or capsules. Major drawbacks of the treatment are side effects of the drugs and patients' incompliance to them. These are consequences of high doses and long-term treatments for the diseases. Currently more than 350 NCI-registered clinical trials are being carried out to treat advanced and/or metastatic melanoma using novel treatment methods, such as immune cell therapy, cancer vaccines, and new therapeutic targets. In addition, novel delivery systems using biomaterials of the approved drugs have been developed attempting to increase the drug delivery, targeting, stability, bioavailability, thus potentially reducing the toxicity and increasing the treatment effectiveness. Nanoparticles and liposomes have been emerging as advanced delivery systems which can improve drug stability and systemic circulation time. In this review, the most recent findings in the options for treatment and development of novel drug delivery systems for the treatment of melanoma are comprehensively discussed.

Regulation of Structure and Anion-Exchange Performance of Layered Double Hydroxide: Function of the Metal Cation Composition of a Brucite-like Layer

As anion-exchange materials, layered double hydroxides (LDHs) have attracted increasing attention in the fields of selective adsorption and separation, controlled drug release, and environmental remediation. The metal cation composition of the laminate is the essential factor that determines the anion-exchange performance of LDHs. Herein, we review the regulating effects of the metal cation composition on the anion-exchange properties and LDH structure. Specifically, the internal factors affecting the anion-exchange performance of LDHs were analyzed and summarized. These include the intercalation driving force, interlayer domain environment, and LDH morphology, which significantly affect the anion selectivity, anion-exchange capacity, and anion arrangement. By changing the species, valence state, size, and mole ratio of the metal cations, the structural characteristics, charge density, and interlayer spacing of LDHs can be adjusted, which affect the anion-exchange performance of LDHs. The present challenges and future prospects of LDHs are also discussed. To the best of our knowledge, this is the first review to summarize the essential relationship between the metal ion composition and anion-exchange performance of laminates, providing important insights for regulating the anion-exchange performance of LDHs.

Biofunctional Layered Double Hydroxide Nanohybrids for Cancer Therapy

Layered double hydroxides (LDHs) with two-dimensional nanostructure are inorganic materials that have attractive advantages such as biocompatibility, facile preparation, and high drug loading capacity for therapeutic bioapplications. Since the intercalation chemistry of DNA molecules into the LDH materials were reported, various LDH nanohybrids have been developed for biomedical drug delivery system. For these reasons, LDHs hybridized with numerous therapeutic agents have a significant role in cancer imaging and therapy with targeting functions. In this review, we summarized the recent advances in the preparation of LDH nanohybrids for cancer therapeutic strategies including gene therapy, chemotherapy, immunotherapy, and combination therapy.

Layered double hydroxide-based nanomaterials for biomedical applications

Against the backdrop of increased public health awareness, inorganic nanomaterials have been widely explored as promising nanoagents for various kinds of biomedical applications. Layered double hydroxides (LDHs), with versatile physicochemical advantages including excellent biocompatibility, pH-sensitive biodegradability, highly tunable chemical composition and structure, and ease of composite formation with other materials, have shown great promise in biomedical applications. In this review, we comprehensively summarize the recent advances in LDH-based nanomaterials for biomedical applications. Firstly, the material categories and advantages of LDH-based nanomaterials are discussed. The preparation and surface modification of LDH-based nanomaterials, including pristine LDHs, LDH-based nanocomposites and LDH-derived nanomaterials, are then described. Thereafter, we systematically describe the great potential of LDHs in biomedical applications including drug/gene delivery, bioimaging diagnosis, cancer therapy, biosensing, tissue engineering, and anti-bacteria. Finally, on the basis of the current state of the art, we conclude with insights on the remaining challenges and future prospects in this rapidly emerging field.

Preparation and application of pH-responsive drug delivery systems

Microenvironment-responsive drug delivery systems (DDSs) can achieve targeted drug delivery, reduce drug side effects and improve drug efficacies. Among them, pH-responsive DDSs have gained popularity since the pH in the diseased tissues such as cancer, bacterial infection and inflammation differs from a physiological pH of 7.4 and this difference could be harnessed for DDSs to release encapsulated drugs specifically to these diseased tissues. A variety of synthetic approaches have been developed to prepare pH-sensitive DDSs, including introduction of a variety of pH-sensitive chemical bonds or protonated/deprotonated chemical groups. A myriad of nano DDSs have been explored to be pH-responsive, including liposomes, micelles, hydrogels, dendritic macromolecules and organic-inorganic hybrid nanoparticles, and micron level microspheres. The prodrugs from drug-loaded pH-sensitive nano DDSs have been applied in research on anticancer therapy and diagnosis of cancer, inflammation, antibacterial infection, and neurological diseases. We have systematically summarized synthesis strategies of pH-stimulating DDSs, illustrated commonly used and recently developed nanocarriers for these DDSs and covered their potential in different biomedical applications, which may spark new ideas for the development and application of pH-sensitive nano DDSs.

Advanced drug delivery applications of layered double hydroxide

Layered double hydroxides (LDHs), also known as anionic clays or hydrotalcite-like compounds, are a class of nanomaterials that attained great attention as a carrier for drug delivery applications. The lamellar structure of this compound exhibits a high surface-to-volume ratio which enables the intercalation of therapeutic agents and releases them at the target site, thereby reducing the adverse effect. Moreover, the intercalated drug can be released in a sustained manner, and hence the frequency of drug administration can be decreased. The co-precipitation, ion exchange, manual grinding, and sol-gel methods are the most employed for their synthesis. The unique properties like the ease of synthesis, low cost, high biocompatibility, and low toxicity render them suitable for biomedical applications. This review presents the advances in the structure, properties, method of preparation, types, functionalization, and drug delivery applications of LDH. Also, this review provides various new conceptual insights that can form the basis for new research questions related to the drug delivery applications of LDH.

Exploitation of new approach to control of environmental pathogenic bacteria causing bovine clinical mastitis using novel anti-biofilm nanocomposite

New approaches are required for prevention and control of biofilm-producing bacteria and consequently mitigating the health problems of bovine clinical mastitis. This work designed to determine prevalence rates of biofilm-producing bacteria that causing bovine clinical mastitis and evaluate the anti-biofilm effectiveness of novel nanocomposite of zinc-aluminum layered double hydroxide intercalated with gallic acid (GA) as chelating agent (Zn-Al LDH/GA) on the prevention and control of environmental pathogenic bacteria; Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), Staphylococcus aureus (S. aureus), and Coagulase-negative staphylococci (CNS), besides Listeria monocytogenes (L. monocytogenes) and assess the ability to use as an antimicrobial agent, and/or sanitizer for milking equipment. All samples (n = 230) involved clinical mastitis cow's milk (n = 50) beside environmental samples (n = 180) were collected then examined for isolation and identification of bacterial pathogens. Zn-Al LDH/GA nanocomposite was synthesized using co-precipitation method, then characterized by Fourier-transform infrared spectroscopy (FT-IR); X-ray diffraction (XRD); field emission scanning electron microscopy (FESEM); high-resolution transmission electron microscopy (HRTEM); thermogravimetric analysis (TGA); differential thermal analysis (DTA); zeta potential; DLS analysis; and Brunauer, Emmett, and Teller (BET) surface area. The anti-biofilm activity of nanocomposite against mastitis-causing bacteria was detected using the broth micro-dilution and disc-diffusion assay. Results, the minimum concentration of Zn-Al LDH/GA that inhibited the growth of gram-positive and negative bacteria, were 312-625 and 5000 μg/mL, respectively. The LD₅₀ of Zn-Al LDH/GA was determined in mice at 1983.3 mg/kg b.wt. As a conclusion, Zn-Al LDH/GA nanocomposite proved its efficiency as an antimicrobial agent and/or sanitizer used for cleaning of milking equipment, due to it could inhibit the growth and multiplication of potentially pathogenic bacteria that causing clinical mastitis and its formation of biofilm on the milking equipment. Zn-Al LDH/GA was found to use under varying pH conditions compared with other commercial sanitizer used besides the formation of nanocomposite increases the material stability.

DFT study on MgAl-layered double hydroxides with different interlayer anions: structure, anion exchange, host–guest interaction and basic sites

The guest anions play a key role in the construction of layered double hydroxide (LDH)-based host–guest functional materials.

Electrochemical Approach for the Production of Layered Double Hydroxides with a Well-Defined Co/MeIII Ratio

Layered double hydroxides (LDHs) have been widely studied for their plethora of fascinating features and applications. The potentiostatic electrodeposition of LDHs has been extensively applied in the literature as a fast and direct method to substitute classical chemical routes. However, the electrochemical approach does not usually allow for a fine control of the M^II /M^III ratio in the synthesized material. By employing a recently proposed potentiodynamic method, LDH films of controlled composition are herein prepared with good reproducibility, using different ratios of the trivalent (Fe or Al) to bivalent (Co) cations in the electrolytic solution. All the obtained materials are shown to be effective oxygen evolution reaction (OER) catalysts, and are thoroughly characterized by a multi-technique approach, including FE-SEM, XRD, Raman, AES and a wide range of electrochemical procedures.

Surfactant-modified Zn/Al-layered double hydroxides for efficient extraction of alkyl phenols from aqueous samples

Zn/Al-layered double hydroxides (LDHs) modified by sodium dodecylsulfate (SDS) were synthesized as a hydrophobic organic sorbent via urea hydrolysis. LDHs were applied as adsorbent for solid phase extraction (SPE) analysis to determine three alkylphenols (namely, p-tert-amylphenol (PTAP), p-cumylphenol (PCP), and p-n-octylphenol (POP)) in water samples using gas chromatography-mass spectrometry. The extraction efficiency was optimized by adjusting key variables of eluent volume, eluent type, sample flow rate, adsorbent amount, pH, and the effect of salt addition. Under the optimal conditions, APs showed excellent linearity (1-250 ng/mL: R² > 0.99) and reproducibility (relative standard deviation: <5%). The detection limits for PTAP, PCP, and POP were 19, 16, and 33 pg/mL, respectively. LDHs based SPE method offered high recovery for aqueous samples (e.g., 83.2-99.46%) with enhanced reusability (e.g., up to 10 cycles). The feasibility of the developed method has thus been validated for quantitation of three alkyl phenols (i.e., PTAP, PCP, and POP) in aqueous environmental samples with high sensitivity and good stability.

Layered Double Hydroxides: A Toolbox for Chemistry and Biology

Layered double hydroxides (LDHs) are an emergent class of biocompatible inorganic lamellar nanomaterials that have attracted significant research interest owing to their high surface-to-volume ratio, the capability to accumulate specific molecules, and the timely release to targets. Their unique properties have been employed for applications in organic catalysis, photocatalysis, sensors, drug delivery, and cell biology. Given the widespread contemporary interest in these topics, time-to-time it urges to review the recent progresses. This review aims to summarize the most recent cutting-edge reports appearing in the last years. It firstly focuses on the application of LDHs as catalysts in relevant chemical reactions and as photocatalysts for organic molecule degradation, water splitting reaction, CO2 conversion, and reduction. Subsequently, the emerging role of these materials in biological applications is discussed, specifically focusing on their use as biosensors, DNA, RNA, and drug delivery, finally elucidating their suitability as contrast agents and for cellular differentiation. Concluding remarks and future prospects deal with future applications of LDHs, encouraging researches in better understanding the fundamental mechanisms involved in catalytic and photocatalytic processes, and the molecular pathways that are activated by the interaction of LDHs with cells in terms of both uptake mechanisms and nanotoxicology effects.